In yet another study by Fu et al., the authors reported that the compound JNJ-1013 degraded IRAK1 with a DC50 of 3 nM in the activated B-cell-like diffuse large B-cell lymphoma cell line HBL-1 [50]. This evidence concerns the gene IRAK1 and diffuse large B-cell lymphoma.